Takeda Pharmaceutical Co. Ltd. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.
Stock Exchange	Other OTC
EPS	$1.56
Market Cap	$56 B
Shares Outstanding	794.7 M
Public Float	-

Takeda Pharmaceutical Co. Ltd. ADR
Stock Exchange	Other OTC
EPS	$0.68
Market Cap	$32.79 B
Shares Outstanding	1.59 B
Public Float	-

Takeda Pharmaceutical Co. Ltd.
Stock Exchange	Frankfurt Stock Exchange
EPS	EUR1.33
Market Cap	EUR49.06 B
Shares Outstanding	794.7 M
Public Float	-

Takeda Pharmaceutical Co. Ltd.
Stock Exchange	Tokyo Stock Exchange
EPS	JPY173.29
Market Cap	JPY6.08 T
Shares Outstanding	1.58 B
Public Float	1.48 B

Profile

Address	4-1-1 Dosho-machi Osaka Osaka 540 Japan
Employees	-
Website	http://www.takeda.co.jp
Updated	07/08/2019
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

Financials

Jean-Luc Butel

Independent Outside Director

Christophe Weber

President, CEO & Representative Director